Jupiter Asset Management LTD Vertex Pharmaceuticals Inc Transaction History

Jupiter Asset Management LTD

$11 Billion
Q3 2024

A detailed history of Jupiter Asset Management LTD transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Jupiter Asset Management LTD holds 159,927 shares of VRTX stock, worth $63.9 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

159,927

Previous 585 27237.95%

Holding current value

$63.9 Million

Previous $274,000 27045.26%

% of portfolio

0.68%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$460.0 - $505.78 $73.3 Million - $80.6 Million	159,342 Added 27237.95%	159,927 $74.4 Million
Q2 2024 Aug 08, 2024	SELL	$392.81 - $485.53 $35.4 Million - $43.8 Million	-90,194 Reduced 99.36%	585 $274,000
Q1 2024 May 10, 2024	SELL	$407.69 - $446.08 $29.6 Million - $32.4 Million	-72,637 Reduced 44.45%	90,779 $37.9 Million
Q4 2023 Feb 09, 2024	BUY	$343.0 - $410.68 $40.2 Million - $48.1 Million	117,210 Added 253.67%	163,416 $66.5 Million
Q3 2023 Nov 09, 2023	BUY	$338.18 - $362.46 $123,773 - $132,660	366 Added 0.8%	46,206 $16.1 Million
Q2 2023 Aug 10, 2023	SELL	$314.42 - $351.91 $39.4 Million - $44.1 Million	-125,179 Reduced 73.2%	45,840 $16.1 Million
Q1 2023 May 10, 2023	BUY	$283.23 - $323.1 $11.5 Million - $13.1 Million	40,504 Added 31.03%	171,019 $53.9 Million
Q4 2022 Feb 10, 2023	BUY	$285.76 - $321.48 $11.1 Million - $12.5 Million	38,968 Added 42.57%	130,515 $37.7 Million
Q3 2022 Nov 10, 2022	SELL	$273.83 - $305.53 $9.17 Million - $10.2 Million	-33,485 Reduced 26.78%	91,547 $26.5 Million
Q2 2022 Aug 10, 2022	SELL	$234.96 - $292.55 $231,435 - $288,161	-985 Reduced 0.78%	125,032 $35.2 Million
Q1 2022 May 11, 2022	BUY	$221.42 - $260.97 $27.2 Million - $32.1 Million	123,034 Added 4124.51%	126,017 $32.9 Million
Q4 2021 Feb 11, 2022	SELL	$177.01 - $223.45 $53.8 Million - $67.9 Million	-303,880 Reduced 99.03%	2,983 $664,000
Q3 2021 Nov 10, 2021	BUY	$181.39 - $202.99 $47.2 Million - $52.9 Million	260,450 Added 561.16%	306,863 $55.7 Million
Q2 2021 Aug 10, 2021	BUY	$187.49 - $221.1 $8.7 Million - $10.3 Million	46,413 New	46,413 $9.36 Million
Q1 2021 May 12, 2021	SELL	$207.02 - $241.31 $11.1 Million - $13 Million	-53,800 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$207.01 - $276.09 $5.42 Million - $7.23 Million	26,174 Added 94.74%	53,800 $12.7 Million
Q3 2020 Nov 10, 2020	BUY	$255.65 - $303.1 $7.06 Million - $8.37 Million	27,626 New	27,626 $7.51 Million

Others Institutions Holding VRTX

# of Institutions

1,725

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $103B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jupiter Asset Management LTD, based on Form 13F filings with the SEC.

News

Stay updated on Jupiter Asset Management LTD with notifications on news.

Account

Jupiter Asset Management LTD Vertex Pharmaceuticals Inc Transaction History